W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0361/2022 : EMA decision of 9 September 2022 on the granting of a product specific waiver for Gallium 68-labelled Prostate-Specific Membrane Antigen-11 (68Ga-PSMA-11) (EMEA-003236-PIP01-22)